-
1
-
-
0034003003
-
Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein
-
Yeung K, Janosch P, McFerran B, et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 2000;20:3079-85.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 3079-3085
-
-
Yeung, K.1
Janosch, P.2
McFerran, B.3
-
2
-
-
0033539167
-
Suppression of RaM kinase activity and MAP kinase signalling by RKIP
-
Young K, Seitz T, Li S, et al. Suppression of RaM kinase activity and MAP kinase signalling by RKIP. Nature 1999;401:173-7.
-
(1999)
Nature
, vol.401
, pp. 173-177
-
-
Young, K.1
Seitz, T.2
Li, S.3
-
3
-
-
0034791116
-
Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation
-
Yeung KC, Rose DW, Dhillon AS, et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001;21:7207-17.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 7207-7217
-
-
Yeung, K.C.1
Rose, D.W.2
Dhillon, A.S.3
-
4
-
-
4143071652
-
The role of Raf kinase inhibitor protein (RKIP) in health and disease
-
Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004;68:1049-53.
-
(2004)
Biochem Pharmacol
, vol.68
, pp. 1049-1053
-
-
Keller, E.T.1
Fu, Z.2
Brennan, M.3
-
5
-
-
1842557438
-
Raf kinase inhibitor protein: A prostate cancer metastasis suppressor gene
-
Keller ET, Fu Z, Yeung K, et al. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. Cancer Lett 2004;207:131-7.
-
(2004)
Cancer Lett
, vol.207
, pp. 131-137
-
-
Keller, E.T.1
Fu, Z.2
Yeung, K.3
-
6
-
-
31944443578
-
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer
-
Fu Z, Kitagawa Y, Shen R, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006;66:248-56.
-
(2006)
Prostate
, vol.66
, pp. 248-256
-
-
Fu, Z.1
Kitagawa, Y.2
Shen, R.3
-
7
-
-
0038275924
-
Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis
-
Fu Z, Smith PC, Zhang L, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003;95:878-89.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 878-889
-
-
Fu, Z.1
Smith, P.C.2
Zhang, L.3
-
8
-
-
3442883359
-
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines
-
Schuierer MM, Bataille F, Hagan S, et al. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004;64:5186-92.
-
(2004)
Cancer Res
, vol.64
, pp. 5186-5192
-
-
Schuierer, M.M.1
Bataille, F.2
Hagan, S.3
-
9
-
-
33749319933
-
Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells
-
Lee HC, Tian B, Sedivy JM, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006;131:1208-17.
-
(2006)
Gastroenterology
, vol.131
, pp. 1208-1217
-
-
Lee, H.C.1
Tian, B.2
Sedivy, J.M.3
-
10
-
-
18444400873
-
The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein
-
Keller ET, Fu Z, Brennan M. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J Cell Biochem 2005;94:273-8.
-
(2005)
J Cell Biochem
, vol.94
, pp. 273-278
-
-
Keller, E.T.1
Fu, Z.2
Brennan, M.3
-
11
-
-
2342435822
-
RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis
-
Chatterjee D, Bai Y, Wang Z. et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004;279:17515-23.
-
(2004)
J Biol Chem
, vol.279
, pp. 17515-17523
-
-
Chatterjee, D.1
Bai, Y.2
Wang, Z.3
-
12
-
-
27144473329
-
Reduction of RaM kinase inhibitor protein expression correlates with breast cancer metastasis
-
Hagan S, Al-Mulla F, Mallon E, et al. Reduction of RaM kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005;11:7392-7.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7392-7397
-
-
Hagan, S.1
Al-Mulla, F.2
Mallon, E.3
-
13
-
-
34247333383
-
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients
-
Al-Mulla F, Hagan S, Behbehani Al, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006;24:5672-9.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5672-5679
-
-
Al-Mulla, F.1
Hagan, S.2
Behbehani, A.3
-
14
-
-
33746942671
-
Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint
-
Eves EM, Shapiro P, Naik K, et al. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 2006;23:561-74.
-
(2006)
Mol Cell
, vol.23
, pp. 561-574
-
-
Eves, E.M.1
Shapiro, P.2
Naik, K.3
-
15
-
-
33745076490
-
Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q
-
Al-Mulla F, AlFadhli S, Al-Hakim AH, et al. Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q. J Clin Pathol 2006;59:624-30.
-
(2006)
J Clin Pathol
, vol.59
, pp. 624-630
-
-
Al-Mulla, F.1
AlFadhli, S.2
Al-Hakim, A.H.3
-
16
-
-
33646151165
-
Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse
-
Al-Mulla F, Behbehani Al, Bitar MS, et al. Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse. Mod Pathol 2006;19:648-58.
-
(2006)
Mod Pathol
, vol.19
, pp. 648-658
-
-
Al-Mulla, F.1
Behbehani, A.2
Bitar, M.S.3
-
17
-
-
0032896905
-
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
-
Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1474-1481
-
-
Harvey, J.M.1
Clark, G.M.2
Osborne, C.K.3
-
18
-
-
0034652572
-
Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation
-
Duigou F, Herlin P, Marnay J, et al. Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation. Cytometry 2000;42:35-42.
-
(2000)
Cytometry
, vol.42
, pp. 35-42
-
-
Duigou, F.1
Herlin, P.2
Marnay, J.3
-
19
-
-
0035083680
-
Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer
-
Risques RA, Moreno V, Marcuello E, et al. Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer. Lab Invest 2001;81:307-15.
-
(2001)
Lab Invest
, vol.81
, pp. 307-315
-
-
Risques, R.A.1
Moreno, V.2
Marcuello, E.3
-
20
-
-
0036635229
-
Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers
-
Tsutsui S, Ohno S, Murakami S, et al. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Oncol Rep 2002;9:793-9.
-
(2002)
Oncol Rep
, vol.9
, pp. 793-799
-
-
Tsutsui, S.1
Ohno, S.2
Murakami, S.3
-
21
-
-
0031840930
-
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality
-
Al-Mulla F, Going JJ, Sowden ET, et al. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 1998;185:130-8.
-
(1998)
J Pathol
, vol.185
, pp. 130-138
-
-
Al-Mulla, F.1
Going, J.J.2
Sowden, E.T.3
-
22
-
-
0033052966
-
Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression
-
Al-Mulla F, Milner-White EJ, Going JJ, et al. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression. J Pathol 1999;187:433-8.
-
(1999)
J Pathol
, vol.187
, pp. 433-438
-
-
Al-Mulla, F.1
Milner-White, E.J.2
Going, J.J.3
-
23
-
-
0033621361
-
MAPK mediates RAS-induced chromosome instability
-
Saavedra HI, Fukasawa K, Conn CW, et al. MAPK mediates RAS-induced chromosome instability. J Biol Chem 1999;274:38083-90.
-
(1999)
J Biol Chem
, vol.274
, pp. 38083-38090
-
-
Saavedra, H.I.1
Fukasawa, K.2
Conn, C.W.3
-
24
-
-
33744542795
-
Raf kinase inhibitor protein regulation of Raf and MAPK signaling
-
Hagan S, Garcia R, Dhillon A, et al. Raf kinase inhibitor protein regulation of Raf and MAPK signaling. Methods Enzymol 2005;407:248-59.
-
(2005)
Methods Enzymol
, vol.407
, pp. 248-259
-
-
Hagan, S.1
Garcia, R.2
Dhillon, A.3
-
25
-
-
33750992148
-
Regulation of RKIP binding to the N-region of the Raf-1 kinase
-
Park S, Rath O, Beach S, et al. Regulation of RKIP binding to the N-region of the Raf-1 kinase. FEBS Lett 2006;580:6405-12.
-
(2006)
FEBS Lett
, vol.580
, pp. 6405-6412
-
-
Park, S.1
Rath, O.2
Beach, S.3
-
26
-
-
19944410494
-
RKIP downregulates B-Raf kinase activity in melanoma cancer cells
-
Park S, Yeung ML, Beach S, et al. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 2005;24:3535- 40.
-
(2005)
Oncogene
, vol.24
, pp. 3535-3540
-
-
Park, S.1
Yeung, M.L.2
Beach, S.3
-
27
-
-
21644484717
-
Raf kinase inhibitory protein regulates RaM but not B-Raf kinase activation
-
Trakul N, Menard RE, Schade GR, et al. Raf kinase inhibitory protein regulates RaM but not B-Raf kinase activation. J Biol Chem 2005;280:24931-40.
-
(2005)
J Biol Chem
, vol.280
, pp. 24931-24940
-
-
Trakul, N.1
Menard, R.E.2
Schade, G.R.3
-
28
-
-
18144412429
-
Guilt by association? p53 and the development of aneuploidy in cancer
-
Duensing A, Duensing S. Guilt by association? p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun 2005;331:694-700.
-
(2005)
Biochem Biophys Res Commun
, vol.331
, pp. 694-700
-
-
Duensing, A.1
Duensing, S.2
-
29
-
-
0029826170
-
p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers
-
Kahlenberg MS, Stoler DL, Basik M, et al. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J Natl Cancer Inst 1996;88:1665-70.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1665-1670
-
-
Kahlenberg, M.S.1
Stoler, D.L.2
Basik, M.3
-
30
-
-
33749182353
-
Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis
-
Minoo P, Baker K, Goswami R, et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006;55:1467-74.
-
(2006)
Gut
, vol.55
, pp. 1467-1474
-
-
Minoo, P.1
Baker, K.2
Goswami, R.3
-
31
-
-
34249709470
-
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer
-
Minoo P, Zlobec I, Baker K, et al. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 2007;127:820-7.
-
(2007)
Am J Clin Pathol
, vol.127
, pp. 820-827
-
-
Minoo, P.1
Zlobec, I.2
Baker, K.3
|